ScreenerHero

0KHE Revvity, Inc.

LSE · GB · Healthcare · Biotechnology · revvity.com
155.30USD+0.28%Mkt Cap: —P/E: 25.18

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and servi…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value19.60B USD
Revenue (TTM)2.91B USD
Gross Profit1.60B USD
Net Income (TTM)237.37M USD
Revenue/Share25.77 USD
Last Price155.30 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees11.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS7140461093
Valuation
P/E (Trailing)25.18
P/E (Forward)—
PEG—
EV/EBITDA22.38
EV/Revenue6.73
P/S—
P/B2.38
EPS (TTM)6.16
EPS (Forward)—
52W Range
80.0086% of range167.56
52W High167.56 USD
52W Low80.00 USD
Profitability
Gross Margin54.98%
Oper. Margin17.05%
EBITDA Margin30.08%
Profit Margin8.16%
ROE3.21%
ROA2.37%
Growth
Revenue Growth1.30%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF627.63M USD
CapEx (TTM)—
FCF Margin20.78%
FCF Yield—
Net Debt2.32B USD
Net Debt/EBITDA2.65
Balance Sheet
Debt/Equity46.23
Current Ratio1.80
Quick Ratio1.36
Book Value/Sh64.78 USD
Cash/Share9.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.28 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.111.24M
Float102.49M
Insiders0.26%
Institutions96.59%
Technical
SMA 50107.07 (+45.0%)
SMA 200110.50 (+40.5%)
Beta1.06
S&P 52W Chg15.78%
Avg Vol (30d)488
Avg Vol (10d)62
Technical Indicators
RSI (14)69.6
MACD8.0627
MACD Signal8.1294
MACD Hist.-0.0667
BB Upper165.70 USD
BB Middle144.81 USD
BB Lower123.93 USD
BB Width28.85%
ATR (14)6.499 USD
Vol Ratio (20d)0.68x